BFIM
GOSS icon

Beese Fulmer Investment Management’s Gossamer Bio GOSS Stock Holding History

Beese Fulmer Investment Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,135
Closed -$3.66K – 445
2026
Q1 		$3.66K Buy
+11,135
New +$17.5K ﹤0.01% 435

Other funds holding GOSS

CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
WA
Waddell & Associates Memphis, Tennessee $2.02B AUM 36.49% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
SCP
Sivia Capital Partners Mill Valley, California $822M AUM 48.82% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

Beese Fulmer Investment Management's GOSS Position: Q2 2026 in Review

Beese Fulmer Investment Management sold out of Gossamer Bio (GOSS) in Q2 2026, closing a stake of 11,135 shares — an estimated $3.66K sold.

Beese Fulmer Investment Management first reported a position in GOSS in Q1 2026 and held it in 1 quarter. The position peaked at $3.66K in Q1 2026. 36 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Beese Fulmer Investment Management reported no remaining Gossamer Bio position as of Q2 2026 after selling out during the quarter.
  • Beese Fulmer Investment Management sold 11,135 Gossamer Bio shares in Q2 2026, an estimated $3.66K.
  • Beese Fulmer Investment Management first reported a position in Gossamer Bio in Q1 2026 and held it in 1 quarter.
  • Beese Fulmer Investment Management's Gossamer Bio position peaked at $3.66K in Q1 2026.
  • 36 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Beese Fulmer Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.